Michael Koffler Email

VP, Finance . Pulse Biosciences

Current Roles

Employees:
70
Revenue:
$39.9M
About
Pulse Biosciences (NASDAQ:PLSE) is a medical technology company developing a therapeutic tissue treatment platform based on Nano-Pulse Electro-Signaling, a proprietary bioelectronics cell signaling technology. Published pre-clinical studies have shown that a single, brief exposure of Nano-Pulse Electro-Signaling to target tissue initiates a cascade of events within cells and in the surrounding microenvironment that results in apoptosis (cell death) and the priming of a durable adaptive immune response. Pulse Biosciences is pursuing a variety of applications for its technology that exploits the technology’s unique biologic effect in immuno-oncology, dermatology, aesthetics, and veterinary medicine. Clinical studies are being planned using the first commercial system designed to support a broad array of electrodes for use in superficial, minimally-invasive, and open surgical procedures.
Pulse Biosciences Address
3957 Point Eden Way
Hayward, CA
United States
Pulse Biosciences Email

Past Companies

Pulse Biosciences, Inc.Vice President, Finance
Pulse Biosciences, Inc.Senior Director of Finance
Cutera, Inc.Senior Director, Financial Planning Analysis

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.